| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocryst Pharmaceuticals Inc (BCRX) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. BCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.32M | $12.32M | - | |
| Pres | 902.6K | $8.39M | - | |
| Other | 398.8K | $3.71M | - | |
| CFO | 268.7K | $2.50M | - | |
| Dir | 93.2K | $866.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2018 | Powell Lynne | Senior VP - CCO | Sale+OE | 100 | $8.00 | $800.00 | -1.1% | |
| Nov 5, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 215 | $8.00 | $1,720.00 | -0.2% | |
| Nov 2, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 10,856 | $7.84 | $85,089.68 | -3.8% | |
| Nov 2, 2018 | Powell Lynne | Senior VP - CCO | Sale+OE | 1,000 | $8.00 | $8,000.00 | -10.4% | |
| Nov 1, 2018 | Powell Lynne | Senior VP - CCO | Sell | 1,544 | $7.51 | $11,595.44 | -15.2% | |
| Oct 19, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 3,150 | $7.45 | $23,467.50 | -2.2% | |
| Oct 19, 2018 | Powell Lynne | Senior VP - CCO | Sell | 100 | $7.50 | $750.00 | -1.0% | |
| Oct 3, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 9,850 | $7.24 | $71,357.78 | -1.8% | |
| Aug 9, 2018 | Sheridan William P67 | Senior VP - CMO | Sale+OE | 62,500 | $7.03 | $439,375.00 | -72.9% | |
| Jun 1, 2018 | Sheridan William P67 | Senior VP - CMO | Sale+OE | 42,112 | $6.30 | $265,305.60 | -66.7% |